Table 1 The correlation analysis of CHADS2 and clinical data in STEMI patients
Index | Low group (n = 205)) | Middle group (n = 247) | High group (n = 72) | Z/F/χ2 | P |
|---|---|---|---|---|---|
Age | 54.52 ± 9.64 | 63.62 ± 13.3 | 72.54 ± 9.89 | 81.026 | < 0.001 |
Gender | 25.364 | < 0.001 | |||
Female | 23 (4.4%) | 53 (10.1%) | 27 (5.2%) | ||
Male | 182 (34.7%) | 194 (37.0%) | 45 (8.6%) | ||
LVEF | 59.85 ± 9.87 | 57.26 ± 10.15 | 55.45 ± 10.43 | 5.398 | 0.005 |
LDL-C | 3.10 ± 0.89 | 2.94 ± 0.94 | 2.67 ± 1.05 | 4.33 | 0.015 |
BNP | 656.8 (248.1–1343.5) | 1140 (485–2501) | 2442 (830.1–4907) | 48.07 | < 0.001 |
LP(a) | 14.81(9.1–31.7) | 15.72(9–28.7) | 16.04(9.95–25.85) | 0.173 | 0.919 |
Hypertension | 61 (11.6%) | 168 (32.1%) | 63 (12.0%) | 103.761 | < 0.001 |
Hyperlipidemia | 170 (32.4%) | 211 (40.3%) | 54 (10.3%) | 4.826 | 0.104 |
Diabetes | 21 (4.0%) | 111 (21.2%) | 47 (9.0%) | 97.895 | < 0.001 |
TIA | 0 (0%) | 10 (1.9%) | 47 (9.0%) | 260.627 | < 0.001 |
Atrial fibrillation | 4 (0.8%) | 14 (2.7%) | 8 (1.5%) | 10.487 | 0.005 |
Killip | |||||
1 | 172 (32.8%) | 96 (18.3%) | 14 (2.7%) | 172.469 | < 0.001 |
2 | 32 (6.1%) | 125 (23.9%) | 35 (6.7%) | ||
≥ 3 | 1 (1.2%) | 26 (5.0%) | 23 (4.4%) | ||
History of PCI | 9 (1.7%) | 9 (1.7%) | 3 (0.6%) | 0.367 | 0.903 |